Research
- Research
- Biosimilars
- Drug Abuse Prevention
- Drug Adherence Programs
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Employers, Unions, & Insurers
- FEHB Program
- Formulary Design
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Health Insurance Marketplace (ACA)
- Home Delivery of Drugs
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- REMS Management
- Specialty Benefit Design
- Specialty Pharmacies
- Specialty Pharmacy Networks
- TRICARE
Rebates Unrelated to Higher Drug Prices
May 01, 2023
There are no plan or PBM rebates in Part B, yet there are substantial price increases....
Share of Drug Dollar Retained by Drug Supply Chain Participants
April 11, 2023
90% of the Rx dollar is retained by drug manufacturers and pharmacies....
The PBM Marketplace Continues to Evolve
April 11, 2023
PBM companies vary in size, geographic footprint, and service offerings, which creates a marketplace with a variety of options for...
The Number of Independent Pharmacies Remains Stable
March 11, 2023
Over the last five years, the marketplace for independent pharmacies has experienced small fluctuations from year-to-year sometimes gaining stores, sometimes...
PBM Management of Specialty Drugs
March 11, 2023
Payer-aligned specialty pharmacies have the technology and clinical expertise to enhance the safety, quality, and affordability of care for patients...
APPENDIX: White Bagging Dispensing
February 11, 2023
APPENDIX: White Bagging Dispensing. Assumptions and methodology for national white bagging savings estimates....
The Independent Pharmacy Marketplace is Still Stable
February 11, 2023
Between January 2022 and January 2023, the total number of independent pharmacies nationwide increased by 99, a 0.4% increase. Looking...
PHARMACY AUDITS An Important Tool for Fighting Fraud, Waste, and Abuse and Protecting Patients
January 11, 2023
PBMs use pharmacy audits to ensure patients receive high-quality services from network pharmacies and to verify that no FWA is...
Patient Access to Biosimilars Is Increasing as Prices Are Decreasing
December 11, 2022
A new research paper from Matrix Global Advisors, Improvements in Medical Benefit Coverage of Biosimilars, finds that commercial medical benefit...